【英語タイトル】Hysteroscope Market Research Report by Product, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Single User(1名利用、印刷可)USD4,949 ⇒換算¥732,452見積依頼/購入/質問フォーム
Enterprise License(企業利用、印刷可)USD9,949 ⇒換算¥1,472,452見積依頼/購入/質問フォーム
360iResearch社は、2021年に378.62百万ドルであった世界の子宮鏡市場規模が、2022年に468.86百万ドルに成長し、更に年平均24.00%拡大して2027年までに1,377.02百万ドルに達すると予測しています。当市場調査レポートでは、子宮鏡の世界市場を多角的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別(軟性子宮鏡、硬性子宮鏡)分析、用途別(子宮内膜アブレーション、筋腫切除術、ポリープ切除術)分析、エンドユーザー別(外来手術センター、婦人科クリニック、病院)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容を掲載しています。また、当書内の企業情報には、B. Braun Melsungen AG、Boston Scientific Corporation、CONMED Corporation、Cook Medical、Coopersurgical Inc.、Ethicon, Inc.、Fortimedix Surgical、Hologic, Inc.、Hospiline Equipments Pvt. Ltd.、Johnson & Johnson Services, Inc、Karl Storz GmbH & Co. KGなどが含まれています。
- 軟性子宮鏡の市場規模
- 硬性子宮鏡の市場規模
- 子宮内膜アブレーションにおける市場規模
- 筋腫切除術における市場規模
- ポリープ切除術における市場規模
- 外来手術センターにおける市場規模
- 婦人科クリニックにおける市場規模
- 病院における市場規模
- 南北アメリカの子宮鏡市場規模
- アジア太平洋の子宮鏡市場規模
- ヨーロッパ/中東/アフリカの子宮鏡市場規模
- その他地域の子宮鏡市場規模
❖ レポートの概要 ❖

The Global Hysteroscope Market size was estimated at USD 378.62 million in 2021 and expected to reach USD 468.86 million in 2022, and is projected to grow at a CAGR 24.00% to reach USD 1,377.02 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Hysteroscope to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Flexible Hysteroscope and Rigid Hysteroscope.

Based on Application, the market was studied across Endometrial Ablation, Myomectomy, and Polypectomy.

Based on End-user, the market was studied across Ambulatory Surgical Centers, Gynecology Clinics, and Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hysteroscope market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hysteroscope Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hysteroscope Market, including B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Coopersurgical Inc., Ethicon, Inc., Fortimedix Surgical, Hologic, Inc., Hospiline Equipments Pvt. Ltd., Johnson & Johnson Services, Inc, Karl Storz GmbH & Co. KG, Koninklijke Philips N.V., Life Care Medical Devices, Maxer Medizintechnik GmbH, Medgyn Products, Inc., Medicon EG, Medtronic PLC, Olympus Corporation, PENTAX Medical, Richard Wolf GmbH, Silex Medical, LLC, Smith+Nephew PLC, SonoScape Medical Corp, Stryker Corporation, Welch Allyn, and XION GmbH.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Hysteroscope Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hysteroscope Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hysteroscope Market?
4. What is the competitive strategic window for opportunities in the Global Hysteroscope Market?
5. What are the technology trends and regulatory frameworks in the Global Hysteroscope Market?
6. What is the market share of the leading vendors in the Global Hysteroscope Market?
7. What modes and strategic moves are considered suitable for entering the Global Hysteroscope Market?

❖ レポートの目次 ❖

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers Changing lifestyles and food habits increased cases of infertility among women Rising prevalence of women related diseases such as abnormal uterine bleeding, and transcervical sterilizations Surge in demand attributed to minimal blood loss and speedy recovery
5.1.2. Restraints Presence of alternatives such as ultrasound, complete blood count, and drug therapies
5.1.3. Opportunities Technological developments and advancements improve equipment and instrumentation Ongoing development and demand for minimally invasive diagnosis
5.1.4. Challenges Probable side effects such as nausea and diarrhea
5.2. Cumulative Impact of COVID-19

6. Hysteroscope Market, by Product
6.1. Introduction
6.2. Flexible Hysteroscope
6.3. Rigid Hysteroscope

7. Hysteroscope Market, by Application
7.1. Introduction
7.2. Endometrial Ablation
7.3. Myomectomy
7.4. Polypectomy

8. Hysteroscope Market, by End-user
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Gynecology Clinics
8.4. Hospitals

9. Americas Hysteroscope Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Hysteroscope Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Hysteroscope Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. B. Braun Melsungen AG
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Boston Scientific Corporation
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. CONMED Corporation
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Cook Medical
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Coopersurgical Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Ethicon, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Fortimedix Surgical
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Hologic, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Hospiline Equipments Pvt. Ltd.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Johnson & Johnson Services, Inc
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Karl Storz GmbH & Co. KG
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Koninklijke Philips N.V.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Life Care Medical Devices
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Maxer Medizintechnik GmbH
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Medgyn Products, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Medicon EG
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Medtronic PLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Olympus Corporation
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. PENTAX Medical
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Richard Wolf GmbH
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Silex Medical, LLC
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Smith+Nephew PLC
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. SonoScape Medical Corp
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Stryker Corporation
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Welch Allyn
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. XION GmbH
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

★調査レポート[世界の子宮鏡市場(~2027):製品別、用途別、エンドユーザー別、地域別] (コード:MRC2305D145)販売に関する免責事項を必ずご確認ください。